US officials deny Trump required breathing aid after hospitalization

Trump announced that both he and the first lady had contracted the illness in the early hours of Friday morning, and he has since been moved to the Walter Reed center for treatment

trump

US President Donald Trump has begun taking an antiviral therapy after testing positive for the coronavirus, his doctor said, noting that he is responding well so far and does not require supplemental oxygen to aid his breathing.

“This afternoon, in consultation with specialists from Walter Reed and Johns Hopkins University, I recommended movement of the president up to Walter Reed National Military Medical Center for further monitoring,” wrote Sean Conley, the president’s physician.

Read more: PM Imran wishes ‘speedy recovery’ for corona-positive US President Trump

“I am very happy to report that the president is doing very well. He is not requiring any supplemental oxygen, but in consultation with specialists we have elected to initiate Remdesivir therapy. He has completed his first dose and is resting comfortably.”

Trump announced that both he and the first lady had contracted the illness in the early hours of Friday morning, and he has since been moved to the Walter Reed center for treatment on Conley’s advice. In his last post on Twitter late on Friday night, Trump said his stay at the hospital was “going well.”

Trump aide Hope Hicks was the first in a series of White House officials and lawmakers to test positive, with her results made public on Thursday night.

Read more: The case of Trump vs American deep state

Less than one day later, 9 others have reported contracting the illness, including a White House staffer, three reporters, former presidential adviser Kellyanne Conway, GOP Sens. Mike Lee (Utah) and Thom Tillis (North Carolina) and University of Notre Dame president Rev. John Jenkins. All of them attended a White House event last Saturday, where Trump announced his new Supreme Court pick, Amy Coney Barrett.

RT with additional input by GVS News Desk

Facebook Comments

blank